The Regulation of Proprotein Convertase Subtilisin/ Kexin Type 9 and Its Liver Involvement
R. G. Mihăilă · Journal of Advances in Medicine and Medical Research · 2017
Introduction: Anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies have been very effective to lower low-density lipoprotein (LDL)-cholesterol. They attracted the attention on PCSK9 enzyme role in multiple pathways and underlined the complex correlations between...
Open access
Research Article
10.9734/BJMMR/2017/33548